Cargando…

Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease

PURPOSE: Adherence to medication can be assessed by various self-report questionnaires. One could hypothesize that survey respondents tend to answer questions in a manner that will be viewed favorably by others. We aimed to answer if anonymous and nonanonymous responses to a questionnaire on medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Prell, Tino, Schaller, Denise, Perner, Caroline, Franke, Gabriele Helga, Witte, Otto W, Kunze, Albrecht, Grosskreutz, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342145/
https://www.ncbi.nlm.nih.gov/pubmed/30697036
http://dx.doi.org/10.2147/PPA.S186732
_version_ 1783389080592056320
author Prell, Tino
Schaller, Denise
Perner, Caroline
Franke, Gabriele Helga
Witte, Otto W
Kunze, Albrecht
Grosskreutz, Julian
author_facet Prell, Tino
Schaller, Denise
Perner, Caroline
Franke, Gabriele Helga
Witte, Otto W
Kunze, Albrecht
Grosskreutz, Julian
author_sort Prell, Tino
collection PubMed
description PURPOSE: Adherence to medication can be assessed by various self-report questionnaires. One could hypothesize that survey respondents tend to answer questions in a manner that will be viewed favorably by others. We aimed to answer if anonymous and nonanonymous responses to a questionnaire on medication adherence differ. PATIENTS AND METHODS: Adherence was assessed with the German Stendal Adherence with Medication Score (SAMS), which includes 18 questions with responses based on a 5-point Likert scale. Anonymous data from 40 subjects were collected during a symposium for patients with Parkinson’s disease (PD), and nonanonymous data were obtained from 40 outpatient-clinic PD patients at the Department of Neurology. RESULTS: The two groups (anonymous self-reported questionnaire and nonanonymous) did not differ in terms of demographical characteristics and the SAMS sum score. However, anonymously collected data showed significant higher scoring for the item 6 (“Do you forget your medications?”) than the data collected nonanonymously (P=0.017). All other items of the SAMS did not significantly differ between both groups. CONCLUSION: Overall assessment of adherence does not depend on whether the patient remains anonymous or not. There seems to be no relevant social desirability bias in nonanonymous responses.
format Online
Article
Text
id pubmed-6342145
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63421452019-01-29 Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease Prell, Tino Schaller, Denise Perner, Caroline Franke, Gabriele Helga Witte, Otto W Kunze, Albrecht Grosskreutz, Julian Patient Prefer Adherence Short Report PURPOSE: Adherence to medication can be assessed by various self-report questionnaires. One could hypothesize that survey respondents tend to answer questions in a manner that will be viewed favorably by others. We aimed to answer if anonymous and nonanonymous responses to a questionnaire on medication adherence differ. PATIENTS AND METHODS: Adherence was assessed with the German Stendal Adherence with Medication Score (SAMS), which includes 18 questions with responses based on a 5-point Likert scale. Anonymous data from 40 subjects were collected during a symposium for patients with Parkinson’s disease (PD), and nonanonymous data were obtained from 40 outpatient-clinic PD patients at the Department of Neurology. RESULTS: The two groups (anonymous self-reported questionnaire and nonanonymous) did not differ in terms of demographical characteristics and the SAMS sum score. However, anonymously collected data showed significant higher scoring for the item 6 (“Do you forget your medications?”) than the data collected nonanonymously (P=0.017). All other items of the SAMS did not significantly differ between both groups. CONCLUSION: Overall assessment of adherence does not depend on whether the patient remains anonymous or not. There seems to be no relevant social desirability bias in nonanonymous responses. Dove Medical Press 2019-01-18 /pmc/articles/PMC6342145/ /pubmed/30697036 http://dx.doi.org/10.2147/PPA.S186732 Text en © 2019 Prell et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Short Report
Prell, Tino
Schaller, Denise
Perner, Caroline
Franke, Gabriele Helga
Witte, Otto W
Kunze, Albrecht
Grosskreutz, Julian
Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
title Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
title_full Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
title_fullStr Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
title_full_unstemmed Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
title_short Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
title_sort comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with parkinson’s disease
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342145/
https://www.ncbi.nlm.nih.gov/pubmed/30697036
http://dx.doi.org/10.2147/PPA.S186732
work_keys_str_mv AT prelltino comparisonofanonymousversusnonanonymousresponsestoamedicationadherencequestionnaireinpatientswithparkinsonsdisease
AT schallerdenise comparisonofanonymousversusnonanonymousresponsestoamedicationadherencequestionnaireinpatientswithparkinsonsdisease
AT pernercaroline comparisonofanonymousversusnonanonymousresponsestoamedicationadherencequestionnaireinpatientswithparkinsonsdisease
AT frankegabrielehelga comparisonofanonymousversusnonanonymousresponsestoamedicationadherencequestionnaireinpatientswithparkinsonsdisease
AT witteottow comparisonofanonymousversusnonanonymousresponsestoamedicationadherencequestionnaireinpatientswithparkinsonsdisease
AT kunzealbrecht comparisonofanonymousversusnonanonymousresponsestoamedicationadherencequestionnaireinpatientswithparkinsonsdisease
AT grosskreutzjulian comparisonofanonymousversusnonanonymousresponsestoamedicationadherencequestionnaireinpatientswithparkinsonsdisease